Dimitra Vlachopoulou

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Deciphering the role of HMGA2 and let-7 microRNAs in myelodysplastic neoplasms with bone marrow fibrosis.

Deciphering the role of HMGA2 and let-7 microRNAs in myelodysplastic neoplasms with bone marrow fibrosis.

Journal: Leukemia & lymphoma

Published: February 24, 2026

Real-life experience of luspatercept in transfusion-dependent lower risk myelodysplastic syndrome patients.

Real-life experience of luspatercept in transfusion-dependent lower risk myelodysplastic syndrome patients.

Journal: British journal of haematology

Published: January 17, 2025

MicroRΝΑ analysis in patients with myelodysplastic neoplasms. Possible implications in risk stratification.

MicroRΝΑ analysis in patients with myelodysplastic neoplasms. Possible implications in risk stratification.

Journal: Leukemia & lymphoma

Published: October 08, 2024

Immunogenicity and Safety of the Recombinant Adjuvanted Herpes Zoster Vaccine in Patients with Chronic Lymphocytic Leukemia and Multiple Myeloma.

Immunogenicity and Safety of the Recombinant Adjuvanted Herpes Zoster Vaccine in Patients with Chronic Lymphocytic Leukemia and Multiple Myeloma.

Journal: Vaccines

Published: September 15, 2024

A study of platelet function in patients with chronic immune thrombocytopenia treated with thrombopoietin receptor agonists.

A study of platelet function in patients with chronic immune thrombocytopenia treated with thrombopoietin receptor agonists.

Journal: Thrombosis research

Published: August 09, 2024

A myelodysplastic neoplasm with del(5q) treated with luspatercept uncovers unexplored mechanisms of action for the drug.

A myelodysplastic neoplasm with del(5q) treated with luspatercept uncovers unexplored mechanisms of action for the drug.

Journal: British journal of haematology

Published: July 26, 2024

Novel Perspectives on Thrombopoietin Receptor Agonists Applications.

Novel Perspectives on Thrombopoietin Receptor Agonists Applications.

Journal: Hamostaseologie

Published: March 18, 2024

Unmet Horizons: Assessing the Challenges in the Treatment of TP53-Mutated Acute Myeloid Leukemia.

Unmet Horizons: Assessing the Challenges in the Treatment of TP53-Mutated Acute Myeloid Leukemia.

Journal: Journal of clinical medicine

Published: December 27, 2023

Cardioselective versus Non-Cardioselective Beta-Blockers and Outcomes in Patients with Atrial Fibrillation and Chronic Obstructive Pulmonary Disease.

Cardioselective versus Non-Cardioselective Beta-Blockers and Outcomes in Patients with Atrial Fibrillation and Chronic Obstructive Pulmonary Disease.

Journal: Journal of clinical medicine

Published: March 30, 2023

Risk of arterial thromboembolism, bleeding and mortality in atrial fibrillation patients with comorbid cancer: A systematic review and meta-analysis.

Risk of arterial thromboembolism, bleeding and mortality in atrial fibrillation patients with comorbid cancer: A systematic review and meta-analysis.

Journal: Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese

Published: March 26, 2023

Bacillus Cereus in Hematological Malignancies.

Bacillus Cereus in Hematological Malignancies.

Journal: Mediterranean journal of hematology and infectious diseases

Published: July 12, 2022

Immunogenicity of a third dose of the BNT162b2 COVID-19 vaccine in patients with CLL: effects on treatment selection.

Immunogenicity of a third dose of the BNT162b2 COVID-19 vaccine in patients with CLL: effects on treatment selection.

Journal: Annals of hematology

Published: May 06, 2022

Showing 1-12 of 14

Last Updated: 09/26/2026